Compare · ILMN vs TRUP
ILMN vs TRUP
Side-by-side comparison of Illumina Inc. (ILMN) and Trupanion Inc. (TRUP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMN and TRUP operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $33.97B, about 24.3x TRUP ($1.40B).
- ILMN has been more active in the news (11 items in the past 4 weeks vs 8 for TRUP).
- ILMN has more recent analyst coverage (25 ratings vs 13 for TRUP).
- Company
- Illumina Inc.
- Trupanion Inc.
- Price
- -
- -
- Market cap
- $33.97B
- $1.40B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 11
- 8
- Recent ratings
- 25
- 13
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Trupanion Inc.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Latest ILMN
- Director Meister Keith A. sold $145,556,398 worth of shares (679,574 units at $214.19) (SEC Form 4)
- SVP, Strategy/Corp Development Wedel Christensen Jakob sold $197,840 worth of shares (1,033 units at $191.52), decreasing direct ownership by 7% to 14,023 units (SEC Form 4)
- SEC Form 8-K filed by Illumina Inc.
- Illumina Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 8-K filed by Illumina Inc.
- SEC Form 3 filed by new insider Coletti Julie Ann
- SEC Form FWP filed by Illumina Inc.
- Chief Commercial Officer Sullivan Michael C was granted 4,503 shares (SEC Form 4)
- Illumina Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Director Meister Keith A. sold $148,159,897 worth of shares (741,127 units at $199.91) (SEC Form 4)
Latest TRUP
- Trupanion downgraded by Piper Sandler with a new price target
- CEO Tooth Margaret sold $28,411 worth of shares (978 units at $29.05) as part of a pre-agreed trading plan, decreasing direct ownership by 0.55% to 175,401 units (SEC Form 4)
- SEC Form 3 filed by new insider Seawell Katherine
- Trupanion Enhances Free Veterinary Education Course to Help Hospital Teams Navigate Cost-of-Care Conversations
- SEC Form 10-Q filed by Trupanion Inc.
- Trupanion Reports Second Quarter 2026 Results
- Trupanion Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Less Paperwork. More Pets. The Long-Awaited Trupanion and Digitail Integration Is Here
- Chief Operating Officer Gallagher John R sold $10,809 worth of shares (431 units at $25.08) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 32,203 units (SEC Form 4)
- Trupanion Announces Second Quarter 2026 Earnings Release and Conference Call